Hedge Fund - Perceptive Advisors
Cerevel Therapeutics Holdings Inc. (CERE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q3 (2024-09-30) | $0 | 0% | 0 | $42.53 |
| 2 | 2024 - Q2 (2024-06-30) | $441,402,480 | 10.63% | 10,794,876 | $41.64 |
| 3 | 2024 - Q1 (2024-03-31) | $456,299,409 | 7.98% | 10,794,876 | $42.00 |
| 4 | 2023 - Q4 (2023-12-31) | $464,924,183 | 10.37% | 10,965,193 | $28.73 |
| 5 | 2023 - Q3 (2023-09-30) | $220,229,445 | 7.34% | 10,088,385 | $25.02 |
| 6 | 2023 - Q2 (2023-06-30) | $320,709,759 | 9.28% | 10,088,385 | $30.69 |
| 7 | 2023 - Q1 (2023-03-31) | $158,851,021 | 4.69% | 6,511,727 | $29.35 |
| 8 | 2022 - Q4 (2022-12-31) | $205,379,869 | 5.76% | 6,511,727 | $28.22 |
| 9 | 2022 - Q3 (2022-09-30) | $184,021,000 | 5.34% | 6,511,727 | $29.78 |
| 10 | 2022 - Q2 (2022-06-30) | $134,493,000 | 4.21% | 5,086,727 | $28.39 |
| 11 | 2022 - Q1 (2022-03-31) | $178,086,000 | 3.56% | 5,086,727 | $29.20 |
| 12 | 2021 - Q4 (2021-12-31) | $164,911,000 | 2.54% | 5,086,727 | $35.28 |
| 13 | 2021 - Q3 (2021-09-30) | $150,058,000 | 2.17% | 5,086,727 | $28.07 |
| 14 | 2021 - Q2 (2021-06-30) | $118,956,000 | 1.54% | 4,643,095 | $14.32 |
| 15 | 2021 - Q1 (2021-03-31) | $63,749,000 | 0.8% | 4,643,095 | $14.63 |
| 16 | 2020 - Q4 (2020-12-31) | $75,340,000 | 0.8% | 4,544,062 | $12.99 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center